CAS: 99212-30-3; (2S,3R,4S,5R)-2-Methylpiperidine-3,4,5-Triol

该化合物其结构特征为丙烯酸盐环,有助于其生物活动;该化合物主要研究其潜在的治疗用途,特别是病毒感染和某些类型癌症的治疗;该化合物由于能够干扰丙烯酸盐的加工,因此具有潜在的治疗用途;脱氧磷酸盐是一种碳水化合物类比,抑制了该病毒的复制,从而表现出了抗艾滋病毒的活动;此外,该化合物可能具有对甘油化合物相互作用至关重要的遗传学领域的影响;该化合物的特点是其水和有机溶液的溶解性及其在各种条件下的稳定性;与许多非尼诺糖一样,其生物影响与它模拟天然糖的能力密切相关,使其能够以独特方式与生物系统发生相互作用.

结构式图片

相似化合物

210174-73-5 19130-96-2 73465-43-7

MSDS等安全信息

    上下游产品

    1,5-dideoxy-1,5-imino-3, 4-O-isopropylidene-L-fucitol 2,3,4-Tri-O-benzoyl-1,5-didesoxy-1,5-imino-L-fucit (2S,3R,4S,5R)-4-Benzyloxy-2-methyl-piperidine-3,5-diol (2S,3R,4S,5R)-1-Benzhydryl-2-methyl-piperidine-3,4,5-triol1,5-Didesoxy-1,5-imino-N-methyl-L-fucit -L-fucit1,5-Didesoxy-1,5-imino-N-5-(methoxycarbonyl)pentyl-L-fucit N-Benzyl-1,5-didesoxy-1,5-imino-L-fucit

    合成工艺路线路线简述

    • 合成目标产物 Deoxyfuconojirimycin, Hydrochloride 主要起始原料 1,3-Dioxolo4,5-Cpyridin-7-Ol, Hexahydro-2,2,4-Trimethyl-, (3Ar,4S,7R,7As)-
    • (文献来源)合成步骤主要原料 1,3-Dioxolo4,5-Cpyridin-7-Ol, Hexahydro-2,2,4-Trimethyl-, (3Ar,4S,7R,7As)-
    📜Methyl Tri-O-Benzoyl-α-D-Arabinofuranoside置于palladium On Activated Charcoal 吡啶,咪唑,Lithium Aluminium Tetrahydride,Sodium Azide,草酰氯,硫酸,氢气,Sodium Methylate,溶剂黄146,二甲基亚砜,三乙胺体系中,用 甲醇,乙醚,二甲基亚砜,N,N-二甲基甲酰胺 作为反应溶剂,化学反应生成 (2S,3R,4S,5R)-2-甲基-3,4,5-哌啶三醇
    参考文献:Syntheses Of L-Fucopyranose And Its Homologs With Ring Heteroatoms Other Than Oxygen. Stereocontrolled Conversion Of A Common D-Arabinofuranoside Intermediate.
    标题:Syntheses Of L-Fucopyranose And Its Homologs With Ring Heteroatoms Other Than Oxygen. Stereocontrolled Conversion Of A Common D-Arabinofuranoside Intermediate.
    摘要:L-岩藻吡喃糖以及几种l-岩藻苷酶抑制剂,5-脱氧-5-硫-L-岩藻吡喃糖和1,5-二脱氧-1,5-亚氨基-L-岩藻醇,均由具有α-D-阿拉伯糖构型的普通戊糖中间体制备而成.通过选择适当的金属有机试剂,成功控制了关键中间体碳链延伸的立体选择性.
    DOI:10.1246/cl.1992.21

    海关参考信息

    专利信息


    专利号:US-4910310-A
    优先权日:1988-10-03
    标 题:Synthesis of N-substituted 1,5-dideoxy-1,5-imino-L-fucitol derivatives
    发明人:CAMPBELL ARTHUR L; BEHLING JAMES R; BABIAK KEVIN A; NG JOHN S; MUELLER RICHARD A; FLEET GEORGE W J
    权利人:SEARLE & CO
    摘要:Novel intermediates and method for the chemical synthesis of N-substituted 1,5-dideoxy-1,5-imino-L-fucitol derivatives are provided. A preferred intermediate is 1,5-dideoxy-1,5-imino-3, 4-O-isopropylidene-L-fucitol which is used to prepare the HIV inhibitor 1,5-dideoxy-1,5-imino-[N-ω-methyl caproate]-L-fucitol. These compounds are prepared in a short synthesis from the known compound 2,3-O-isopropylidene-D-lyxono-1,4-lactone or in a multi-step synthesis from D-galactose.

    专利号:US-5286877-A
    优先权日:1993-02-01
    标 题:Synthesis of 1,4-dideoxy-1,4-imino-L-arabinitol
    发明人:BEHLING JAMES R; MEDICH JOHN R; BABIAK KEVIN A; FLEET GEORGE W J
    权利人:SEARLE & CO
    摘要:1,4-Dideoxy-1,4-imino-L-arabinitol is chemically synthesized from D-lyxonolactone by formation of the pyrrolidine ring by joining the nitrogen between C-1 and C-4 and inversion of configuration at both C-2 and C-4, with the C-3 and C-5 hydroxyl groups being protected throughout the synthesis sequence by benzylidenation. The product is preferably isolated as the hydrochloride salt and is useful as an inhibitor of α-glucosidase and human immunodeficiency virus (HIV).

    专利号:US-5136036-A
    优先权日:1989-05-15
    标 题 :Synthesis of mannojirimycin derivatives
    发明人:FLEET GEORGE W J; BRUCE IAN
    权利人:MONSANTO CO
    摘要:α-Homojirimycin and 6-dpi-homojirimycin are each synthesized from 2-azido-2-deoxy-3,4:6,7-di-O- isopropylidene-D-glydero-D-talo-heptono-1,5-lactone in which the side chain acetonide is hydrolyzed to give the corresponding diol which is then protected with a silyl protecting agent to form a silyl ether. The latter compound is used as a divergent intermediate in which the piperidine ring is formed by joining the nitrogen function at C-2 to C-6 (A) with inversion of configuration at C-6 to form 6-epi-homomannojirimycin or (B) with retention of configuration at C-6 to form α-homomannojirimycin.

    专利号:US-5101027-A
    优先权日:1989-10-11
    标题:Synthesis of mannojirimycin derivatives
    发明人:FLEET GEORGE W J; BRUCE IAN
    权利人:MONSANTO CO
    摘要:alpha -Homojirimycin and 6-dpi-homojirimycin are each synthesized from 2 az ido-2-deoxy-3,4:6,7-di-O-isopropylidene-D-glycero-D-talo-heptono-1,5-l actone in which the side chain acetonide is hydrolyzed to give the corresponding diol which is then protected with a silyl protecting agent to form a silyl ether. The latter compound is used as a divergent intermediate in which the piperidine ring is formed by joining the nitrogen function at C-2 to C-6 (A) with inversion of configuration at C-6 to form 6-epi-homomannojirimycin or (B) with retension of configuration at C-6 to form alpha -homomannojirimycin.

    专利号:US-5096909-A
    优先权日:1989-06-27
    标题 :Fucosidase inhibitor
    发明人:FLEET GEORGE W J; NAMGOONG SUNG K
    权利人:MONSANTO CO
    摘要:The synthesis of the novel fucosidase inhibitor, 2,6-imino-2,6,7-trideoxy-D-glycero-D-gluco heptitol, is disclosed.

    专利号:US-5153325-A
    优先权日:1989-06-27
    标题:Fucosidase inhibitor
    发明人:FLEET GEORGE W J; NAMGOONG SUNG K
    权利人:MONSANTO CO
    摘要:The synthesis of the novel fucosidase inhibitor, 2,6-imino-2,6,7-trideoxy-D-glycero-D-gluco heptitol, is disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/s0960-894x(02)00627-3
    摘要:Ogawa S, Mori M, Takeuchi G, Doi F, Watanabe M, Sakata Y. Convenient synthesis and evaluation of enzyme inhibitory activity of several N-alkyl-, N-phenylalkyl, and cyclic isourea derivatives of 5a-carba-alpha-DL-fucopyranosylamine. Bioorg Med Chem Lett. 2002 Oct 21;12(20):2811–4. doi: 10.1016/s0960-894x(02)00627-3.
    参考文献:10.1055/s-0030-1259947
    摘要:Qing F, Zheng F. Synthesis of Trifluoromethylated and gem-Difluoromethylenated Biologically Interesting Compounds from Fluorine-Containing Synthons. Synlett. 2011 Apr 07;2011(08):1052–72. doi: 10.1055/s-0030-1259947.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知